Healthcare provider profile · identity verified

Christopher Alan Stearns, MD

Internal Medicine · AUSTIN, TX · NPI 1750572947

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	446	96
Levothyroxine Sodium	Levothyroxine Sodium	278	55
Amlodipine Besylate	Amlodipine Besylate	222	58
Eliquis	Apixaban	218	34
Gabapentin	Gabapentin	173	52
Furosemide	Furosemide	157	57
Sertraline Hcl	Sertraline Hcl	155	39
Carvedilol	Carvedilol	149	37
Losartan Potassium	Losartan Potassium	144	33
Tamsulosin Hcl	Tamsulosin Hcl	143	32
Trazodone Hcl	Trazodone Hcl	128	36
Lisinopril	Lisinopril	123	39
Tramadol Hcl	Tramadol Hcl	123	37
Pantoprazole Sodium	Pantoprazole Sodium	118	46
Potassium Chloride	Potassium Chloride	111	34
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	100	38
Levetiracetam	Levetiracetam	100	18
Lorazepam	Lorazepam	91	32
Pravastatin Sodium	Pravastatin Sodium	86	12
Montelukast Sodium	Montelukast Sodium	85	18
Metoprolol Tartrate	Metoprolol Tartrate	79	23
Duloxetine Hcl	Duloxetine Hcl	78	21
Fluoxetine Hcl	Fluoxetine Hcl	78	14
Oxycodone Hcl	Oxycodone Hcl	73	40
Clopidogrel	Clopidogrel Bisulfate	69	20
Donepezil Hcl	Donepezil Hcl	69	17
Omeprazole	Omeprazole	65	29
Fluticasone Propionate	Fluticasone Propionate	58	28
Pregabalin	Pregabalin	57	15
Metoprolol Succinate	Metoprolol Succinate	56	14
Finasteride	Finasteride	55	suppressed
Xarelto	Rivaroxaban	55	suppressed
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	54	37
Amiodarone Hcl	Amiodarone Hcl	52	12
Mirtazapine	Mirtazapine	51	20
Allopurinol	Allopurinol	49	suppressed
Memantine Hcl	Memantine Hcl	48	13
Escitalopram Oxalate	Escitalopram Oxalate	46	15
Budesonide	Budesonide	44	13
Clonazepam	Clonazepam	41	suppressed
Gentamicin Sulfate	Gentamicin Sulfate	41	suppressed
Latanoprost	Latanoprost	41	12
Ondansetron Hcl	Ondansetron Hcl	41	33
Quetiapine Fumarate	Quetiapine Fumarate	41	14
Bupropion Xl	Bupropion Hcl	37	suppressed
Citalopram Hbr	Citalopram Hydrobromide	35	suppressed
Fentanyl	Fentanyl	34	suppressed
Torsemide	Torsemide	34	12
Valacyclovir	Valacyclovir Hcl	33	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	32	11
Chlorhexidine Gluconate	Chlorhexidine Gluconate	32	suppressed
Albuterol Sulfate	Albuterol Sulfate	31	suppressed
Metformin Hcl	Metformin Hcl	31	21
Tizanidine Hcl	Tizanidine Hcl	31	11
Alprazolam	Alprazolam	30	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	30	suppressed
Prednisone	Prednisone	30	15
Ezetimibe	Ezetimibe	29	suppressed
Famotidine	Famotidine	28	11
Hydralazine Hcl	Hydralazine Hcl	28	13
Midodrine Hcl	Midodrine Hcl	28	suppressed
Xifaxan	Rifaximin	28	suppressed
Brimonidine Tartrate	Brimonidine Tartrate	27	suppressed
Farxiga	Dapagliflozin Propanediol	27	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	27	suppressed
Lamotrigine	Lamotrigine	27	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	27	suppressed
Enoxaparin Sodium	Enoxaparin Sodium	25	suppressed
Methocarbamol	Methocarbamol	25	13
Rosuvastatin Calcium	Rosuvastatin Calcium	25	14
Sucralfate	Sucralfate	25	suppressed
Divalproex Sodium	Divalproex Sodium	24	suppressed
Meloxicam	Meloxicam	24	suppressed
Morphine Sulfate	Morphine Sulfate	24	13
Spironolactone	Spironolactone	24	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	22	suppressed
Myrbetriq	Mirabegron	22	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	21	15
Benztropine Mesylate	Benztropine Mesylate	21	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	21	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	21	suppressed
Lovastatin	Lovastatin	21	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	21	suppressed
Veltassa	Patiromer Calcium Sorbitex	21	suppressed
Estradiol	Estradiol	20	suppressed
Liothyronine Sodium	Liothyronine Sodium	20	suppressed
Olanzapine	Olanzapine	20	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	19	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	19	suppressed
Hydrocortisone	Hydrocortisone	19	suppressed
Paroxetine Hcl	Paroxetine Hcl	19	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	19	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	18	15
Simvastatin	Simvastatin	18	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	17	suppressed
Baclofen	Baclofen	17	suppressed
Heparin Sodium	Heparin Sodium,porcine	17	suppressed
Memantine Hcl Er	Memantine Hcl	17	suppressed
Carbamazepine	Carbamazepine	16	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	16	suppressed
Ranolazine Er	Ranolazine	16	suppressed
Ceftriaxone	Ceftriaxone Sodium	15	14
Jardiance	Empagliflozin	15	suppressed
Kerendia	Finerenone	15	suppressed
Lacosamide	Lacosamide	15	suppressed
Methimazole	Methimazole	15	suppressed
Methotrexate	Methotrexate Sodium	15	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	15	11
Sotalol	Sotalol Hcl	15	suppressed
Temazepam	Temazepam	15	suppressed
Admelog Solostar	Insulin Lispro	14	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	14	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	14	suppressed
Levofloxacin	Levofloxacin	14	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	14	suppressed
Rytary	Carbidopa/Levodopa	14	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	14	suppressed
Calcitriol	Calcitriol	13	suppressed
Letrozole	Letrozole	13	suppressed
Phenobarbital	Phenobarbital	13	suppressed
Lidocaine Hcl	Lidocaine Hcl/Pf	12	suppressed
Aripiprazole	Aripiprazole	11	suppressed
Bethanechol Chloride	Bethanechol Chloride	11	suppressed
Brilinta	Ticagrelor	11	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	11	suppressed
Buspirone Hcl	Buspirone Hcl	11	suppressed
Glimepiride	Glimepiride	11	suppressed
Januvia	Sitagliptin Phosphate	11	suppressed
Methenamine Hippurate	Methenamine Hippurate	11	suppressed
Rivastigmine	Rivastigmine Tartrate	11	suppressed
Scopolamine	Scopolamine	11	suppressed
Sodium Chloride	0.9 % Sodium Chloride	11	11

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error